Clinical & Experimental Metastasis

Papers
(The median citation count of Clinical & Experimental Metastasis is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis107
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics51
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches49
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma44
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models28
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption23
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics22
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria21
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression21
Oncolytic intralesional therapy for metastatic melanoma19
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection19
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG19
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss19
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review18
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions17
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression17
Axillary nodal staging in breast cancer: what have we learned?17
Cell blebbing novel therapeutic possibilities to counter metastasis16
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer15
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells15
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis15
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer15
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis14
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker14
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations14
Therapy resistance and metastasis14
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer14
Fluid shear stress influences invasiveness of HeLa cells through the induction of autophagy13
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis13
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection13
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade13
Current preclinical models of brain metastasis13
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells12
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis11
Etiology and treatment of cancer-related secondary lymphedema11
Histopathological growth patterns of neuroendocrine tumor liver metastases11
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study11
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model11
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations11
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis10
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study10
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?10
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK110
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results10
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis10
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics10
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation10
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy9
Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study9
Correction: Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival9
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis9
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases9
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma9
Immune responses and immunotherapeutic approaches in the treatment against cancer8
FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells8
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy8
Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors8
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER28
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer7
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology7
TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer7
Less contrast-enhanced areas within lymph nodes in the delayed phase of contrast-enhanced MRI: a suspicious finding for lymph node metastases7
Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review7
Application of CTC discoveries for liquid biopsy: the RPL/RPS gene signature of melanoma CTCs is linked to brain metastasis onset7
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance6
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer6
Introduction: Novel Frontiers in Cancer Metastasis6
Correction to: Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis6
Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis6
Interrogating the roles of lymph node metastasis in systemic immune surveillance6
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis6
Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells5
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study5
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?5
Membrane Lipid Replacement for reconstituting mitochondrial function and moderating cancer-related fatigue, pain and other symptoms while counteracting the adverse effects of cancer cytotoxic therapy5
Associations amongst genes, molecules, cells, and organs in breast cancer metastasis5
Detecting and monitoring tumors in orthotopic colorectal liver metastatic animal models with high-resolution ultrasound5
International cooperation to fight cancer’s late-stage presentation in low- and middle-income countries5
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review5
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis5
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?5
Downregulation of LINC00886 facilitates epithelial–mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma5
miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF65
CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling5
The role of epigenetic modifications in Colorectal Cancer Metastasis5
Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment5
Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer5
Review old bone, new tricks5
miRNAs in pancreatic cancer progression and metastasis4
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer4
Neoadjuvant therapy for resectable melanoma4
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)4
Factors associated with the distribution of brain metastases in lung cancer: a retrospective study4
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer4
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy4
Cancer metastasis through the lymphatic versus blood vessels4
Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world4
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review4
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer4
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer4
Clinical applications of circulating tumor cells in patients with solid tumors4
0.23025703430176